Teva’s (TEVA) $125 Million BioXcel Bid Offers Upside, but FDA and Auction Risks Remain
Teva Pharmaceutical Industries Limited (NYSE:TEVA) has agreed to serve as the stalking-horse bidder for substantially all of BioXcel Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd (TEVA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Rubric Capital Management David Rosen | 15,575,000 | $527,681,000 | +3% | 4.84% |
| 2. | Alyeska Investment Group Anand Parekh | 6,257,579 | $212,006,777 | +14% | 0.55% |
| 3. | Polar Capital Brian Ashford-Russell And Tim Woolley | 5,212,749 | $176,607,936 | +1% | 0.42% |
| 4. | Glenview Capital Larry Robbins | 5,081,091 | $172,147,363 | -24% | 3.13% |
| 5. | Millennium Management Israel Englander | 3,265,321 | $110,629,075 | +73% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.86 | 1,113 | $20,988.06 | 13,027 | 2025-09-05 | Filing | |
| $9.60 | 104,500 | $1,003,409.00 | 220,442 | 2019-06-04 | Filing | |
| $8.98 | 111,000 | $997,013.10 | 115,942 | 2019-06-03 | Filing | |
| $21.92 | 2,000 | $43,840.00 | 6,445 | 2018-08-03 | Filing | |
| $19.32 | 250,000 | $4,829,700.00 | 1,500,000 | 2018-05-10 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.70 | 314 | $12,152.99 | 8,500 | 2026-09-18 | Filing | |
| $39.15 | 2,525 | $98,841.13 | 8,814 | 2026-09-18 | Filing | |
| $38.69 | 4,503 | $174,221.07 | 11,339 | 2026-09-18 | Filing | |
| $39.06 | 367,600 | $14,356,801.80 | 0 | 2026-09-18 | Filing | |
| $37.63 | 2,500 | $94,076.75 | 13,071 | 2026-08-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 63,894,301 | $2,164,738,902 | 0.03% | |
| 2. | 42,933,367 | $1,454,582,474 | 9.94% | |
| 3. | 41,315,232 | $1,376,210,378 | 2.49% | |
| 4. | 39,854,383 | $1,350,266,496 | 5.27% | |
| 5. | 38,922,212 | $1,318,684,543 | 8.44% |
News See All
Teva (TEVA) Backed a Bid of Up to $125M in Cash Plus Assumed Liabilities for BioXcel’s Assets. Is Bankruptcy-Sale Risk Worth the At-Home Opportunity?
Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Limited (NYSE:TEVA), agreed to serve as the stalking-horse bidder for substantially all assets of BioXcel Therapeutics...
Could Aurinia Pharmaceuticals (AUPH) Stock Win Big After its LUPKYNIS Patent Settlement With Teva Pharmaceuticals (TEVA)?
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) and Teva Pharmaceuticals Industries Limited (NYSE:TEVA) reached a major milestone on August 19, settling their U.S. patent dispute.
TEVA Stock Climbs as 50-Year-Long Tourette Syndrome Drug Breakthrough Moves Closer
Shares in Teva Pharmaceutical Industries ($TEVA) were healthier today after a potential 50-year-long breakthrough treatment for Tourette syndrome m...
Is Teva Pharmaceutical Industries Limited (TEVA) Stock Undervalued After Recent Pullback and Vitiligo Program Update?
We recently compiled a list of the 12 Best Low-Priced Pharma Stocks to Buy Right Now. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best low-priced pharma stocks on this list.
12 Best Low-Priced Pharma Stocks to Buy Right Now
In this article, we will be taking a look at the 12 Best Low-Priced Pharma Stocks to Buy Right Now.
Is Teva Pharmaceutical Industries Limited (TEVA) Strengthening Its Neurology Portfolio With New Austedo Results?
We recently compiled a list of the 10 Best Weight Loss Drug Stocks to Buy in 2026. Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best weight loss drugs on this list.
10 Best Weight Loss Drug Stocks to Buy in 2026
In this article, we will be taking a look at the 10 Best Weight Loss Drug Stocks to Buy in 2026. The anti-obesity drug (AOM) market in the United States is rapidly changing structurally.
7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue
In this article, we will discuss 7 Best Pet Care Stocks to Buy for Consistent Recurring Revenue.
8 Best Middle East and Africa Stocks to Buy According to Hedge Funds
In this article, we will discuss the 8 Best Middle East and Africa Stocks to Buy According to Hedge Funds.
Hedge Fund Resource Center